Immune thrombocytopenia (ITP) is the second indication for which gamgertamig has received Orphan Drug Designation (ODD), following a first ODD for autoimmune hemolytic anemia (AIHA) Dosing is complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback